US OptionsDetailed Quotes
VKTX241122C80000
- 0.68
- 0.000.00%
15min DelayClose Nov 22 16:00 ET
0.00High0.00Low
0.00Open0.68Pre Close0 Volume268 Open Interest80.00Strike Price0.00Turnover0.00%IV48.01%PremiumNov 22, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.68Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma80.16Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Viking Therapeutics Stock Discussion
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
lets gooooooo
No comment yet